1. Home
  2. PSO vs BRKR Comparison

PSO vs BRKR Comparison

Compare PSO & BRKR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pearson Plc

PSO

Pearson Plc

HOLD

Current Price

$13.95

Market Cap

8.4B

ML Signal

HOLD

Logo Bruker Corporation

BRKR

Bruker Corporation

HOLD

Current Price

$45.10

Market Cap

7.0B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
PSO
BRKR
Founded
1844
1960
Country
United Kingdom
United States
Employees
N/A
N/A
Industry
Books
Biotechnology: Laboratory Analytical Instruments
Sector
Consumer Discretionary
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
8.4B
7.0B
IPO Year
2000
2000

Fundamental Metrics

Financial Performance
Metric
PSO
BRKR
Price
$13.95
$45.10
Analyst Decision
Buy
Analyst Count
0
12
Target Price
N/A
$46.45
AVG Volume (30 Days)
797.4K
2.4M
Earning Date
01-01-0001
11-03-2025
Dividend Yield
2.34%
0.44%
EPS Growth
31.65
N/A
EPS
0.90
N/A
Revenue
$4,822,578,436.00
$3,438,900,000.00
Revenue This Year
$2.34
$3.61
Revenue Next Year
$5.09
$1.23
P/E Ratio
$14.69
N/A
Revenue Growth
N/A
6.10
52 Week Low
$12.85
$28.53
52 Week High
$17.90
$64.64

Technical Indicators

Market Signals
Indicator
PSO
BRKR
Relative Strength Index (RSI) 64.07 51.48
Support Level $13.03 $44.96
Resistance Level $14.06 $47.88
Average True Range (ATR) 0.13 1.82
MACD 0.14 -0.55
Stochastic Oscillator 89.64 2.89

Price Performance

Historical Comparison
PSO
BRKR

About PSO Pearson Plc

UK-listed Pearson is a testing and educational provider. Pearson's primary operations are in assessment and qualification testing and higher education, but they also provide English education and testing, virtual learning, prehiring testing and screening, and upskilling/reskilling. The company divested noncore businesses, including the Financial Times, The Economist, and publishing house Penguin, and is now focused on being an educational resource and testing provider.

About BRKR Bruker Corporation

Bruker Corp manufactures scientific instruments and diagnostic tests for customers in the life sciences, applied markets, pharmaceutical, and biotechnology industries. The company operates in segments, namely, Bruker Scientific Instruments (BSI) BioSpin, BSI CALID, BSI Nano, and Supercon Technologies (BEST). The company generates maximum revenue from the BSI CALID segment. Geographically, it derives the maximum of its revenue from United States.

Share on Social Networks: